JellatechAugust 2023
jellatech.com
Actively hiring
Regenerative Medicine
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$5.7M
6 rounds on record
Latest round
$3.5M
Venture round · Aug 2023 · 3 yr ago
Team
11-50
employees, estimated range
Backers
1
byFounders
The money's age
Long since its last round
37 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 23, 2023
Raised a round Venture round $3.5M · SEC Form D
Jan 25, 2023
Raised a round Convertible Note $165k · SEC Form D
Jul 13, 2022
Raised a round Convertible Note $75k · SEC Form D
Nov 17, 2021
Raised a round Convertible Note $926k · SEC Form D
Oct 30, 2021
Raised a round Convertible Note $100k · SEC Form D
Nov 30, 2020
Raised a round Convertible Note $975k · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2023 | $3.5M | — | SEC Form D |
| Convertible Note | Jan 2023 | $165k | — | SEC Form D |
| Convertible Note | Jul 2022 | $75k | — | SEC Form D |
| Convertible Note | Nov 2021 | $926k | — | SEC Form D |
| Convertible Note | Oct 2021 | $100k | — | SEC Form D |
| Convertible Note | Nov 2020 | $975k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Jellatech, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Stephanie MichelsenExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
byFounders Similar startupsby what they do, their industry and backers
Juvena Therapeutics is a clinical-stage biotechnology company engineering proteins that human stem cells naturally secrete into…
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform…
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…
Advance your cell therapy with Cellipont Bioservices, a leading cell therapy CDMO, offering tailored development, analytics, and cGMP…
We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
Overview
Jellatech is building a human cell platform to produce the proteins the body is built from, at scale, on spec. Starting with full-length, triple-helix human collagen type I.
People
Stephanie Michelsen
Executive Officer, Director
Ryan Bethencourt
Director
Peter Andersen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Raleigh
United States
HQ
10-50 est. staff
Financials
Total raised
$5.7M
Latest round
Venture - Series Unknown
Funding rounds
6